Predictive gene tests for cancer are designed to
identify persons who have inherited a gene mutation that may result in
cancer. First candidates are families who have participated in linkage
analysis studies, where the tests have been specifically tailored to pick
out the gene, or gene markers, in their DNA.
Once a gene has been isolated and a test developed, testing becomes
feasible in broader populations. The first candidates might be members of
other very high-risk families that have had several affected members over
at least two generations. Next might be persons with a family history that
is less marked - perhaps one or two relatives with the disease.
Soon genetic tests for some types of inherited colon and breast cancer
may be offered to the public. The targets of the tests would remain the
same: individuals whose body cells carry the disease-causing mutation.
These would be people who have inherited the mutant gene, including those
whose family history is not apparent (for example, a woman who has
acquired the breast cancer susceptibility gene through her father's side
of the family). It would also include people in whom the gene mutated very
early in embryonic development.
It is important to remember that predictive gene tests will be able to
identify only a small proportion of the people who will get, for example,
breast or colon cancer. Most cancers are not inherited, and most people
who get cancer, whether or not they have relatives with it, do not have an
inherited mutation.